1227626-51-8

1227626-51-8 structure

Name: Trityl olmesartan medoxomil impurity III
Chemical Name: (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
CAS Number: 1227626-51-8
Molecular Formula: C₄₈H₄₂N₆O₅
Molecular Weight: 782.88400
Catalog: Research Areas Others
Create Date: 2016-03-27 21:21:51
Modify Date: 2026-07-01 18:32:55
Trityl olmesartan medoxomil impurity III is an impurity of Trityl olmesartan medoxomil. Trityl olmesartan medoxomil is an intermediate of Olmesartan medoxomil[1].

Name	(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
Synonyms	Trityl olMestan MedoxoMil iMpurity III OMJ2 dehydro Impurity (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate Olmestan ester impurity F Olmestan Medoxomil Impurity15 Olmestan Medoxomil Impurity F N-Trityl Des-4-hydroxy Olmestan Medoxomil Azilstan medoxomil impurity237 1H-Imidazole-5-cboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester Olmestan Medoxomil impurity 14/N-Trityl Des-4-hydroxy Olmestan Medoxomil/(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate Trityl olmestan medoxomil im Olmestan Medoxomil Impurity 87 (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cb Olmestan Impurity 26 Olmestan Medoxomil Anhydro N2-Trityl Impurity Olmestan Medoxomil-5

Description	Trityl olmesartan medoxomil impurity III is an impurity of Trityl olmesartan medoxomil. Trityl olmesartan medoxomil is an intermediate of Olmesartan medoxomil[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
References	[1]. Renata Toplak Časar, et al. Development of efficient one-pot three-component assembly of trityl olmesartan medoxomil. Bioorg Med Chem. 2018 Aug 7;26(14):4348-4359.

Precursor 0
DownStream 1
879562-26-2